Status:
COMPLETED
Plasma Transfusion in Liver Transplantation
Lead Sponsor:
Etablissement Français du Sang
Conditions:
Bleeding in Liver Transplantation
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The aim of the study is to compare the clinical efficacy of three types of plasma secured on the viral level either by quarantine or by chemical treatment in patients undergoing liver transplantation.
Detailed Description
Three types of plasma are transfused in bleeding patients undergoing liver transplantation: * quarantined plasma, * methylene blue treated plasma, * solvent/detergent plasma. The main purpose is to s...
Eligibility Criteria
Inclusion
- age 18 yo and above
- consent is signed,
- liver transplantation is indicated,
- plasma is transfused
Exclusion
- multiorgan transplantation (except combined kidney and liver transplantation)
- allergy to methylene blue.
Key Trial Info
Start Date :
June 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2010
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00235183
Start Date
June 1 2005
End Date
December 1 2010
Last Update
February 17 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
EFS
Paris, France, 75015